IPO - PSYENCE BIOMEDICAL LTD.

Form Type: F-1

Filing Date: 2025-01-24

Corporate Action: Ipo

Type: New

Accession Number: 000141057825000041

Filing Summary: On January 23, 2025, Psyence Biomedical Ltd. filed a registration statement for an initial public offering (IPO) under Form F-1. This prospectus addresses the potential offer and sale of a total of 3,075,000 common shares of the company, which includes 380,000 issued shares and various warrant shares. The securities being offered include Series A and Series B common warrants, as well as Pre-Funded Warrants. The exercise prices for the warrants are set at $2.00 for Series A and B warrants and $2.50 for the Placement Agent Warrants. The Series A Warrants will expire five years after issuance, while the Series B Warrants will expire two years post-issuance. The offering is set to take place as soon as the registration statement becomes effective. The company has indicated they will register additional securities if necessary, adhering to the applicable regulations.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2024-12-30

Corporate Action: Ipo

Type: New

Accession Number: 000110465924132289

Filing Summary: Psyence Biomedical Ltd. has filed a request for acceleration of effectiveness of their Registration Statement on Form F-1, originally filed on December 20, 2024, which is set to become effective on December 31, 2024, at 4:00 p.m. Eastern Time. This indicates the company is moving forward with its initial public offering (IPO) process.

Document Link: View Document